Lisa M. Augustine

Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine et al. · Drug Metabolism and Disposition · 2009 · 347 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2

Lauren M. Aleksunes, Angela L. Slitt, Jonathan Maher et al. · Toxicology and Applied Pharmacology · 2007 · 152 citations · Full text

Pharmacy, Pharmacology, Toxicology +13

Induction of Drug-Metabolizing Enzymes by Garlic and Allyl Sulfide Compounds via Activation of Constitutive Androstane Receptor and Nuclear Factor E2-Related Factor 2

Craig D. Fisher, Lisa M. Augustine, Jonathan Maher et al. · Drug Metabolism and Disposition · 2007 · 128 citations

Medicine, Pharmacology, Toxicology +15

Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine et al. · European Journal of Pharmacology · 2009 · 114 citations · Full text

Medicine, Biochemistry, Pathobiology +12

XENOBIOTIC AND ENDOBIOTIC TRANSPORTER MRNA EXPRESSION IN THE BLOOD-TESTIS BARRIER

Lisa M. Augustine, Robert J Markelewicz, Kim Boekelheide et al. · Drug Metabolism and Disposition · 2004 · 106 citations

Life Sciences, Biochemistry, Molecular Biology +11